Henderson Jane

Henderson Jane is listed in filings as Chief Financial Officer at Apogee Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 4, 2026, including sale activity. Recent filings connect the profile to Apogee Therapeutics, Inc. (APGE), Akero Therapeutics, Inc. (AKRO), and CARGO Therapeutics, Inc. Common Stock (CRGX). The current snapshot covers public activity from Aug 23, 2024 to May 4, 2026. Reported amounts are shown as $74.3K to $24.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.